Altathera Pharmaceuticals LLC
At a glance
Employees20-99
In business sinceNot reported
HeadquartersChicago, IL
US patents7
SAM.gov UEIC5U9ZJQMZ5Q5
CAGE code7FYJ8
Incorporated inDE
- intravenous drug therapies
- cardiac arrhythmias
- atrial fibrillation
- atrial flutter
- ventricular arrhythmias
- pediatric patients
- rapid therapeutic assessment
- precise dosing
- serious cardiac conditions
- antiarrhythmic drug initiation
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen OCT 28, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
7 US patents granted 2019–2025, 6 of them in the five years to SEP 2025.
Pharmaceuticals 7
- Sotalol hydrochloride dosingUS 12,403,109 · granted SEP 2, 2025
- Anti-arrhythmic compositions and methodsUS 12,396,970 · granted AUG 26, 2025
- Method of escalating sotalol hydrochloride dosingUS 12,390,431 · granted AUG 19, 2025
- Method of initiating and escalating sotalol hydrochloride dosingUS 11,696,902 · granted JUL 11, 2023
- Antiarrhythmic drug dosing methods, medical devices, and systemsUS 11,610,660 · granted MAR 21, 2023
Newest 5 shown · Granted to AltaThera Pharmaceuticals LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Altathera Pharmaceuticals LLC | Chicago | IL | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.